Selzentry

Type: Product

Name: Selzentry

First reported Feb 20 2013 - Updated Feb 20 2013 - 1 reports

SELZENTRY (Maraviroc) Tablet, Film Coated [REMEDYREPACK INC. ]

Updated Date: Feb 19, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 20 2013]

Entities: Selzentry, Maraviroc

First reported Feb 19 2013 - Updated Feb 19 2013 - 1 reports

SELZENTRY (Maraviroc) Tablet, Film Coated [REMEDYREPACK INC. ]

Updated Date: Feb 19, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 19 2013]

Entities: Selzentry, Maraviroc

First reported Feb 14 2013 - Updated Feb 15 2013 - 2 reports

SELZENTRY (Maraviroc) Tablet, Film Coated [ViiV Healthcare Company]

Updated Date: Feb 7, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 15 2013]

Entities: Selzentry, Maraviroc, ViiV Healthcare

Quotes

Reporters obtained the following quote from the background information supplied by the inventors: "HIV-1 (human immunodeficiency virus-1) infection remains a major medical problem, with an estimated 45 million people infected worldwide at the end of 2007. The number of cases of HIV and AIDS (acquired immunodeficiency syndrome) has risen rapidly. In 2005, approximately 5.0 million new infections were reported, and 3.1 million people died from AIDS. Currently available drugs for the treatment of HIV include nucleoside reverse transcriptase (RT) inhibitors or approved single pill combinations: zidovudine (or AZT or RETROVIR.RTM.), didanosine (or VIDEX.RTM.), stavudine (or ZERIT.RTM.), lamivudine (or 3TC or EPIVIR.RTM.), zalcitabine (or DDC or HIVID.RTM.), abacavir succinate (or ZIAGEN.RTM.), tenofovir disoproxil fumarate salt (or VIREAD.RTM.), emtricitabine (or FTC-EMTRIVA.RTM.), COMBIVIR.RTM. (contains -3TC plus AZT), TRIZIVIR.RTM. (contains abacavir, lamivudine, and zidovudine), Epzicom (contains abacavir and lamivudine), TRUVADA.RTM. (contains VIREAD.RTM. and EMTRIVA.RTM.); non-nucleoside reverse transcriptase inhibitors: nevirapine (or VIRAMUNE.RTM.), delavirdine (or RESCRIPTOR.RTM.) and efavirenz (or SUSTIVA.RTM.), Atripla (TRUVADA.RTM.+SUSTIVA.RTM.), and etravirine, and peptidomimetic protease inhibitors or approved formulations: saquinavir, indinavir, ritonavir, nelfinavir, amprenavir, lopinavir, KALETRA.RTM. (lopinavir and Ritonavir), darunavir, atazanavir (REYATAZ.RTM.) and tipranavir (APTIVUS.RTM.), and integrase inhibitors such as raltegravir (Isentress), and entry inhibitors such as enfuvirtide (T-20) (FUZEON.RTM.) and maraviroc (Selzentry)."

Patent Application Titled "Deuterated Hiv Attachment Inhibit. . . [Published Equities.com - May 01 2013]

More Content

sort by: Date \| Relevance
Patent Application Titled "Deuterated Hiv Attac... [Published Equities.com - May 01 2013]
SELZENTRY (Maraviroc) Tablet, Film Coated [REME... [Published DailyMed Drug Label Updates for the last seven ... - Feb 20 2013]
SELZENTRY (Maraviroc) Tablet, Film Coated [REME... [Published DailyMed Drug Label Updates for the last seven ... - Feb 19 2013]
SELZENTRY (Maraviroc) Tablet, Film Coated [ViiV... [Published DailyMed Drug Label Updates for the last seven ... - Feb 15 2013]
SELZENTRY (Maraviroc) Tablet, Film Coated [ViiV... [Published DailyMed Drug Label Updates for the last seven ... - Feb 14 2013]

Blogs

sort by: Date \| Relevance
SELZENTRY (Maraviroc) Tablet, Film Coated [REME... [Published DailyMed Drug Label Updates for the last seven ... - Feb 20 2013] Updated Date: Feb 19, 2013 EST ...
SELZENTRY (Maraviroc) Tablet, Film Coated [REME... [Published DailyMed Drug Label Updates for the last seven ... - Feb 19 2013] Updated Date: Feb 19, 2013 EST ...
SELZENTRY (Maraviroc) Tablet, Film Coated [ViiV... [Published DailyMed Drug Label Updates for the last seven ... - Feb 15 2013] Updated Date: Feb 7, 2013 EST ...
SELZENTRY (Maraviroc) Tablet, Film Coated [ViiV... [Published DailyMed Drug Label Updates for the last seven ... - Feb 14 2013] Updated Date: Feb 7, 2013 EST ...